Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SynAct Pharma submits clinical trial application for AP1189 in Nephrotic Syndrome

SynAct Pharma AB ("SynAct") today announced that the company has submitted a clinical trial application (CTA) to the Danish Medicines Agency to initiate a Phase IIa study with its lead candidate drug AP1189 in Idiopathic Membranous Nephropathy (IMN). IMN is the single most common cause of Nephrotic Syndrome in adults.In the Phase IIa study, AP1189 will be tested in a double-blind, placebo-controlled multicenter study as add-on therapy to ACE-inh or A2R-ant treatment in a once-daily dose regimen for four weeks with the primary endpoint to show treatment effect on urinary protein excretion

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

Lund, Sweden, 12:00 pm CET, 31 March 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes. During March, the number of shares in BONESUPPORT HOLDING AB (publ) has increased with 760,000 and the number of votes has increased with 103,000 due to the direct share issue and repurchase of 730,000 series C shares as communicated on 2 March 2020; and due to the exercise of warrants. As of 31 March 2020, the number of shares in BONESUPPORT HOLDING AB (publ) amounts to 53,888,740

Consumers in Sweden name Lantmännen one of the most sustainable brands in the country

The Sustainable Brand Index (SBI) survey reveals that Lantmännen is seen as the second most sustainable food brand by Swedish consumers. In the overall index including all categories in the survey, Lantmännen ranks sixth.The Sustainable Brand Index (SBI) – the most comprehensive independent brand survey in Europe focused on sustainability – has now released the results of its B2C/business-to-consumer survey for 2020. Lantmännen continues to rank high, in second place among food brands and sixth overall. What’s more, Lantmännen also ranked number one brand on the Swedish market in the B2B/

Read original

Bonava introduces short-time working for salaried employees in Sweden

As a consequence of the governmental decisions imposed on all of Bonava’s markets for the purpose of limiting the spread of infection from the coronavirus, the company believes there is an increased risk of disruptions to operations. Bonava has therefore decided on short-time working for offices in Sweden.–  Reducing working hours for our office employees in Sweden is one measure among many we have chosen to implement in order to increase flexibility going forward, says Joachim Hallengren, President and CEO of Bonava. The plan is to reduce working hours to 40 per cent for the greater

Breakthrough orders for Senzime in the UK

Press release: Uppsala, March 31, 2020. Senzime AB (publ) today announces that the company has received orders for TetraGraph systems and associated disposable sensors from the NHS-hospitals Medway Maritime Hospital and Sherwood Forest Hospital. The initial order value amounts to about SEK 0.5 million. Medway Maritime Hospital is an NHS-hospital in Gillingham outside London that performs around 30,000 surgeries annually and provides healthcare to almost half a million patients. The NHS Sherwood Forest Hospital provides hospital services to over 420,000 patients annually. Both

Notice to the annual general meeting in Tradedoubler AB (publ)

The shareholders of TradeDoubler AB (publ), reg. no. 556575-7423, are hereby summoned to Annual General Meeting to be held on Thursday 7 May 2020, at 9:00 am, at the company’s premises on Birger Jarlsgatan 57A, 7[th] floor, Stockholm. Registration for the Meeting will commence at 8:45 am. A. Participation Shareholders who wish to participate in the Annual General Meeting must (i) be recorded as shareholders in the register of shareholders maintained by Euroclear Sweden AB (“Euroclear”) on Thursday 30 April 2020, and (ii) notify the company of their intention to attend the Meeting no

Adjusted financial information for Alma Media’s continuing operations for 2019

Alma Media Corporation              Stock Exchange Release               March 31, 2020 at 1.00 p.m. (EEST) ADJUSTED FINANCIAL INFORMATION FOR ALMA MEDIA’S CONTINUING OPERATIONS FOR 2019 Alma Media adjusts its consolidated income statement and segment results for 2019 due to the divestment of the regional news media business and the printing business. Alma Media reported the divested businesses as discontinued operations in the financial statements for 2019. The divested businesses were previously reported primarily under the Alma Consumer segment. The post-divestment estimated and

Preem continues to be the industry’s most sustainable brand

Preem has been named the most sustainable brand in the fuel industry for the third year in a row, according to the Sustainable Brand Index 2020 B2C – Europe’s largest sustainability study, which annually ranks Sweden’s most sustainable brands.Preem won due to its long-term focus on the research and development of renewable fuels, persistent work with Preem Evolution Diesel and efforts to reduce its overall carbon footprint. The study highlighted these areas as being particularly appreciated by consumers. “We are very proud that our sustainability work is delivering results. The fact that

BioStock: FDA grants Cereno Scientific’s lead candidate Orphan Drug Designation

Cereno Scientific is accelerating the building of a platform of drug candidates in epigenetic modulation, by HDAC inhibition, for cardiovascular and rare diseases. On March 10, the company’s main candidate CS1 was approved for Orphan Drug Designation by the FDA for the treatment of Pulmonary Arterial Hypertension.Read the full article at biostock.se: https://www.biostock.se/en/fda-grants-cereno-scientifics-lead-candidate-orphan-drug-designation/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se 

Magnolia Bostad publishes Annual Report for 2019

Magnolia Bostad’s Annual Report for 2019 is now available in Swedish on the company’s website, www.magnoliabostad.se. The English version of the Annual Report for 2019 will be published on Magnolia Bostad’s website before the end of April 2020. Printed Annual Reports in Swedish will be available to order from 22 April 2020 by email at info@magnoliabostad.se or by phone on +46 8 470 50 80. For more information, please contact:Mikaela Senator, IR Manager+46 70 775 57 57, mikaela.senator@magnoliabostad.se Marita Björk, IR and Financial Media Manager+46 72 720 00 06, marita.bjork@

Invitation to a telephone conference today, March 31, at 3:00 pm CET

Analysts, investors and media are invited to participate in a telephone conference at 3:00 p.m. CET today, March 31, on account of Trelleborg’s press release about the Coronavirus. Please see separate press release for details about the event.  Peter Nilsson, President and CEO, and Ulf Berghult, CFO, will participate from Trelleborg. Link to webcast: https://www.trelleborg.com/en/investors/presentations. Please call the conference 5 to 10 minutes prior to the specified time to ensure a punctual start to the meeting. Call: Sweden: +46 8 505 583 65, UK: +44 333 3009 270 or US: +1

NRC Group ASA – Appointed to a contract in Finland – EUR 4.2 million

Finnish Transportation Infrastructure Agency (FTIA) has appointed NRC Group Finland, a company wholly owned by NRC Group ASA, to a railway maintenance contract in South-Western Finland. The contract includes maintenance of railway signalling systems and superstructure including rail points, equipment and devices, and substructure. The contract is valued at approximately EUR 4.2 million and is part of an existing maintenance alliance contract. In the alliance contract, FTIA and NRC Group Finland work together and share the risks and benefits related to the project implementation. The work

Bluestep Bank informs that Bluestep Holding withdraws its dividend proposal

The Board of Directors of Bluestep Holding AB has decided to withdraw the proposed dividend to the Annual General Meeting 2020Bluestep Holding AB owns 100% of Bluestep Bank AB (publ). The dividend decision affects the consolidated situation where the bank is included. ”The Bluestep Group has a very strong capital structure and solid liquidity. Despite this, Bluestep chooses not to make any dividends and thus follows the guidelines that The Swedish Financial Supervisory Authority recently sent out.” states Per-Arne Blomquist, Chairman, Bluestep Holding. For further information, please

New number of votes in Bonava AB due to conversion

The number of shares and votes in Bonava AB has changed due to conversions of a total of 500,000 shares of series A to a total of 500,000 shares of series B.According to Bonava’s articles of association, owner of a share of series A has the right to request that such share is converted to a share of series B. In March 2020, 500,000 shares of series A were converted to 500,000 shares of series B at the request of shareholders. Following the conversions, there were, as of March 31, 2020, the last trading day of the month, a total of 108,435,822 registered shares in Bonava AB. Of these 11,

Conversion of shares in Skanska AB

In conjunction with a conversion of shares, the company is obliged, according to the Financial Instruments Trading Act (1991:980), to disclose information concerning the change.During Mars 2020, 301 Series A shares were converted to Series B shares at the request of shareholders. Accordingly, the total number of votes in the company totals 597,199,598. The total number of registered shares in the company amounts to 419,903,072, of which 19,699,614 are Series A shares, and 400,203,458 are Series B shares.

Change in number of shares and votes in Episurf Medical

Episurf Medical AB (NASDAQ: EPIS B) has, by information previously announced, conducted a directed share issue. Through the first registration of the new issue, the number of shares has increased by 53,333,333 B-shares and the number of votes has increased by 53,333,333.The total number of shares amounts to 144,264,088, of which 971,024 are A shares and 143,293,064 are B shares. The total number of votes after the conversions amounts to 146,206,136. The share capital has increased by SEK 16,013,542.99 and now amounts to SEK 43,315,859.79. For more  information, please contact: Pål

Trelleborg comments the impact of the Coronavirus

Organic sales for Trelleborg for the first quarter 2020 have been negatively impacted by the pandemic, particularly during the latter part of the quarter. The Group has continuously initiated measures to offset the development, entailing that the earnings trend and cash flow have been relatively stable despite the downturn in sales. The measures implemented address both costs and cash flow, and comprise focused cost-savings in the form of, for example, shortened working hours, lay-off notices and redundancies, temporary facility closures and reduced investments, and an intensified focus on

Notice to attend the annual general meeting of Railcare Group AB (publ)

The shareholders of Railcare Group AB (publ), reg. no. 556730-7813, are hereby given notice to attend the annual general meeting to be held at 13:00 CEST, Wednesday 6 May 2020 at the company’s head office, Näsuddsvägen 10 in   Skelleftehamn, Sweden. Registration for the meeting commences at 12:15 CEST. NOTICE OF PARTICIPATION Shareholders who wish to participate in the proceedings of the general meeting must: · be entered in the shareholders’ register kept by Euroclear Sweden AB, as of Wednesday 29 April 2020; and · · notify the company no later than by Wednesday 29

OUTOTEC INITIATES EMPLOYEE COOPERATION NEGOTIATIONS FOR TEMPORARY LAY-OFFS IN FINLAND

Outotec initiates employee cooperation negotiations for temporary lay-offs in FinlandThe exceptional circumstances caused by the coronavirus pandemic impact Outotec’s business. Due to this Outotec initiates employee cooperation negotiations on March 31, 2020, with the personnel in Finland for temporary lay-offs. The temporary lay-offs would last for a maximum of 90 days. The negotiations concern the entire personnel, approximately 1400 employees in Finland. At this stage, the details concerning temporary lay-offs cannot be estimated, as these will be determined in the course of the

CELLINK AB (publ) receives an order of SEK 5,200,000 from the National Board of Health and Welfare in Sweden

CELLINK AB (publ) has received an order for consumables for healthcare through an order from the National Board of Health and Welfare in Sweden, the order value is a total of 5 200 000 SEK. Since the company has expertise and capacity to produce various gels used in the company's bioink products, CELLINK has in recent weeks been working to adjust parts of the production to help with the current situation with COVID-19, including the production of hand sanitizers and test equipment such as qPCR instruments and reagents. The order shall be delivered during the company's third quarter. For

Restore the Faded Glory of Greece in Imperator: Rome Magna Graecia

Greek Focused Content Pack Released Alongside Major Game UpdateSTOCKHOLM - 31 March 2020 - The rise of Macedon overwhelmed the ancient fame of Athens and Sparta. But with the death of Alexander, the prospect of freedom among competing empires offered a chance to revive lost glories. In Magna Graecia, a new content pack for Imperator: Rome, you can play this dangerous game and restore the Greek city-states to imperial power.Imperator: Rome, Paradox Development Studio’s grand strategy game about the classical world, gets a new content pack today. Magna Graecia focuses on enhancing the

Change in the number of shares and votes in Momentum Group AB (publ)

As a result of the issuance of new shares in conjunction with Momentum Group’s recommended public offer to the shareholders of Swedol AB (publ), the number of shares in Momentum Group AB (publ) has increased by 22,633,876 Class B shares. Following the directed share issue, the total number of Class A shares, Class B shares and votes in Momentum Group at 31 March 2020 is as follows:   Number of Number of Class B shares Total number Total number Class A of shares of votes sharesBefore 1,062,436 27,

Navamedic ASA: Enters into distribution agreement for ThermaCare® with Angelini Pharma

Oslo, 3 March 2020 – Navamedic ASA (OSE: NAVA), today announces it has entered into an exclusive distribution agreement with Angelini Pharma for ThermaCare® in the Nordics and the strategically important Dutch market. With the agreement, Navamedic strengthens its position in the Consumer Health segment and enters the important pain category.“We are pleased to announce the agreement with Angelini Pharma for ThermaCare, expanding our portfolio of high-quality products to the benefit of our customers in the Nordics and Netherlands, underpinning the value of our insights, local expertise and

Correction of Earlier Press Release

In the press release the company published earlier today (2020-03-31) at 08.00, there was an incorrect reference to EU’s market abuse regulation. Find the corrected press release below:Stille Publishes Annual Report 2019 Stille AB (publ) today publishes the Annual Report for 2019. Stille’s Annual Report for the business year of 2019 is today being published on the company website www.stille.se. The Annual Report 2019 can also be found in full as an attachment to this press release.  Torshälla, March 31st 2020.

There are no items matching the current filter
There are no more items matching the current filter
Back to top